Nacuity Pharmaceuticals, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
0
Ending by 2030
Mar 2035
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Mar 12 to 26, 2027 · next Mar 12
- 1 fee due Sep 17, 2027The maintenance fee for Method for Preparation of N-Acetyl Cysteine Amide and Derivatives Thereof (US 10,590,073) comes due Sep 17, 2027. Unpaid by Mar 17, 2028, it lapses early.
Recent changes
- 3 of the patents on this record were granted since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,763,902 | Method for preparation of N-acetyl cysteine amide In force · From the USPTO record | In force | From the USPTO record | |
| US 9,889,103 | Method for the preparation of N-acetyl cysteine amide In force · From the USPTO record | In force | From the USPTO record | |
| US 12,472,157 | Treatment of Retinitis Pigmentosa with N-Acetylcysteine Amide In force · High confidence | In force | High confidence | |
| US 12,667,548 | Treatment of Retinitis Pigmentosa and Retinitis Pigmentosa Associated with Usher Syndrome with N-Acetylcysteine Amide In force · High confidence | In force | High confidence | |
| US 10,590,073 | Method for Preparation of N-Acetyl Cysteine Amide and Derivatives Thereof In force · High confidence | In force | High confidence | |
| US 11,091,433 | Method for Preparation of N-Acetyl Cysteine Amide and Derivatives Thereof In force · High confidence | In force | High confidence | |
| US 11,548,851 | Method for Preparation of N-Acetyl Cysteine Amide and Derivatives Thereof In force · High confidence | In force | High confidence | |
| US 12,662,449 | Method for Preparation of N-Acetyl Cysteine Amide and Derivatives Thereof In force · High confidence | In force | High confidence | |
| US 11,753,370 | Methods of Making Deuterium-Enriched N-acetylcysteine Amide (D-NACA) and (2R, 2R')-3,3'-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress In force · High confidence | In force | High confidence | |
| US 12,780,781 | Methods of Making Deuterium-Enriched N-Acetylcysteine Amide (D-NACA) and (2R,2R)-3,3-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
7 pending · 2 abandoned · 1 no status recorded